Memorial Sloan-kettering Cancer Center is a 501(c)(3) organization based in New York, New York, registered in 1962, with $8,499,234,483 in FY2024 revenue. CharityIndex grades it A, and it directs about 99% of spending to programs.
Revenue (FY2024)
$8.5B
▲ 13.9% vs prior year
Health median: $840K
Expenses (FY2024)
$7.9B
Net assets
$10.0B
Employees
25,921
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Memorial Sloan-kettering Cancer Center: 99% to programs · $10 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Memorial Sloan-kettering Cancer Center: 15 mo reserves · +7% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Memorial Sloan-kettering Cancer Center: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Memorial Sloan-kettering Cancer Center: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Leadership in the prevention, treatment, and cure of cancer through excellence, vision and cost effectiveness in patient care, outreach programs, research, and education.
Research: memorial sloan-kettering cancer center maintains one of the world's most dynamic programs of cancer research. the extraordinary patient care we provide benefits from our innovative programs in basic, translational, and clinical research. research at sloan-kettering institute is dedicated to understanding the biology of cancer through programs in cell biology, genetics, biochemistry, molecular biology, structural biology, computational biology, immunology, and therapeutics. investigators at sloan-kettering institute collaborate with memorial hospital physician-scientists, a partnership that helps speed important research findings from the laboratory to the bedside, in a process known as translational research. memorial sloan-kettering cancer center also actively initiates and participates in clinical trials to identify more effective cancer therapies, and our physicians are currently leading more than 1,900 clinical trials for pediatric and adult cancers. the human oncology and pathogenesis program (hopp) is a further effort to increase institutional research strength in areas important in contemporary translational research. hopp is designed to meld even more thoroughly the cultures of basic biologic science and clinical oncology, augmenting the work conducted in the laboratories of memorial sloan-kettering cancer center's physician-scientists.
Education: education is a vital part of memorial sloan-kettering cancer center's mission. our training programs prepare physicians and scientists for careers in the biomedical sciences. our collaborations with the rockefeller university, cornell university, and weill medical college of cornell university offer phd programs in chemical biology, computational biology and medicine, and the medical sciences. the center also partners with weill medical college and the rockefeller university to offer a md/phd degree for aspiring physician-scientists. the center has a phd program in cancer biology through its louis v. gerstner, jr. graduate school of biomedical sciences. this novel program has been enrolling students since 2006 and trains basic laboratory scientists to work in research areas directly relevant to cancer and other human diseases. we also offer postgraduate clinical fellowships to train physicians who seek special expertise in a particular type of cancer and postgraduate research fellowships that provide physicians and scientists with advanced laboratory research training. with faculty appointments at the weill medical college of cornell university, our clinical staff also train residents and medical students.
Revenue grew from $3.4B (FY2013) to $8.5B (FY2024) across 12 reported years.
Financial snapshot
Operating margin
6.9%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$15.5B
Total liabilities
$5.5B
Net assets
$10.0B
Salaries & benefits
$4.0B
50% of expenses
Board members
117
105 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $8,499,234,483▲13.9% | $7,913,348,443▲10.1% | $9,997,707,000▲8.2% | $15,468,483,000▲5.5% | 990 |
| 2023 | $7,462,624,000▲2.9% | $7,188,709,398▲4.9% | $9,237,367,000▲5.7% | $14,659,485,000▲4.7% | 990 |
| 2022 | $7,251,947,000▲4.6% | $6,852,007,000▲11.5% | $8,741,218,000▼11.0% | $13,998,385,000▼6.3% | 990 |
| 2021 | $6,930,810,000▲28.7% | $6,144,357,000▲5.9% | $9,824,842,000▲21.8% | $14,941,252,000▲12.2% | 990 |
| 2020 | $5,383,849,774▼3.2% | $5,799,378,774▲10.3% | $8,068,918,000▲15.7% | $13,315,250,000▲14.6% | 990 |
| 2019 | $5,561,914,000▲8.7% | $5,259,261,000▲12.9% | $6,975,513,000▲8.5% | $11,621,453,000▲9.4% | 990 |
| 2018 | $5,118,490,000▲13.8% | $4,659,570,111▲11.3% | $6,426,091,000▲5.3% | $10,620,542,000▼0.1% | 990 |
| 2017 | $4,499,057,098▲14.2% | $4,184,654,098▲10.7% | $6,102,810,000▲6.6% | $10,632,552,000▲7.6% | 990 |
| 2016 | $3,938,149,398▲1.8% | $3,781,247,199▲7.2% | $5,725,987,199▲3.5% | $9,885,345,175▲3.1% | 990 |
| 2015 | $3,867,024,714▲7.4% | $3,528,902,741▲11.3% | $5,530,882,000▲3.1% | $9,586,730,000▲6.8% | 990 |
| 2014 | $3,601,970,032▲6.4% | $3,169,289,032▲8.7% | $5,364,860,000▲4.3% | $8,977,530,000▲5.8% | 990 |
| 2013 | $3,386,091,872 | $2,916,945,872▲5.5% | $5,143,974,000▲21.5% | $8,481,418,000▲8.8% | 990 |
| 2012 | — | $2,765,697,022▲6.7% | $4,233,052,000▲7.4% | $7,795,608,000▲14.8% | 990 |
| 2011 | — | $2,591,837,584▲9.1% | $3,941,162,000▲1.1% | $6,790,005,000▲5.3% | 990 |
| 2010 | — | $2,375,854,000 | $3,897,526,000 | $6,448,415,000 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Selwyn Vickers Md — $6,637,012 (0.08% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Selwyn Vickers Md | Board Member, President & Ceo | 50 | $6,637,012 |
| Jeffrey Drebin Md | Chairman Attending | 50 | $2,823,914 |
| Babak Mehrara Md | Chief Attending | 50 | $2,603,794 |
| Michael Harrington | Evp & Chief Financial Officer | 50 | $2,532,398 |
| Bernard Bochner | Attending, Surgery | 50 | $2,375,474 |
| Michelle Coriddi Md | Associate Attending, Surgery | 50 | $2,340,489 |
| Jason Klein | Svp & Chief Investment Officer | 50 | $2,271,880 |
| Jonas Nelson Md | Associate Attending, Surgery | 50 | $2,260,579 |
| Lisa Deangelis Md | Chief Physician Executive | 50 | $2,216,824 |
| Shelly Anderson | Hospital President | 50 | $2,160,092 |
| Joan Massague | Chief Scientific Officer & Director of Ski | 50 | $2,076,081 |
| Kenneth Manotti | Svp & Chief Development Officer | 50 | $2,074,775 |
| Erin Mcdonough | Evp, Marketing & Communication Officer | 50 | $1,907,439 |
| Simon Powell Md | Chairman Attending | 50 | $1,900,796 |
| Jorge Lopez Esq | Evp & General Counsel | 50 | $1,675,269 |
| Debra Berns | Svp & Chief Risk Officer | 50 | $1,673,783 |
| Kathryn Martin | Former Chief Operating Officer | 0 | $1,668,982 |
| Remy Evard | Evp, Chief Digital Officer | 50 | $1,613,641 |
| Lakisha Mack | Evp, Chief Administrative Officer | 50 | $1,179,509 |
| Tomya Watt | Former Evp, Interim Chief Human Resources Officer | 50 | $1,155,056 |
| Contractor | Services | Paid |
|---|---|---|
| Cannon Design Architecture | Architecture | $30,649,667 |
| Impact Advisors LLC | Financial Consultants | $28,899,419 |
| Jgn Construction Corp | Construction | $25,163,789 |
| Lend Lease Us Construction | Construction | $14,609,898 |
| Epic Systems Corporation | Software Consultants | $14,281,411 |
162 grants to Memorial Sloan-kettering Cancer Center totaling $66.3M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $275,376 |
| Parker Institute For Cancer Immunotherapy | Support research in field of cancer immunotherapy | 2024 | $167,500 |
| Ayco Charitable Foundation | Medical / public services | 2024 | $80,600 |
| The Community Foundation For Greater Atlanta Inc | Health care | 2024 | $72,500 |
| United Jewish Foundation | To support medical research | 2024 | $50,500 |
| Amalgamated Charitable Foundation Inc | Project support | 2024 | $25,000 |
| Collier Community Foundation Inc | Health | 2024 | $12,255 |
| The Bessemer Giving Fund | Annual giving | 2024 | $10,000 |
| Raymond James Charitable Endowment Fund | General support | 2024 | $9,355 |
| American Gift Fund | Operations | 2024 | $6,000 |
| Parker Institute For Cancer Immunotherapy | Support research in field of cancer immunotherapy | 2023 | $278,726 |
| Cold Spring Harbor Laboratory | Research | 2023 | $145,386 |
| Ayco Charitable Foundation | Medical / public services | 2023 | $73,145 |
| National Philanthropic Tr | Culture & arts | 2023 | $62,750 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2023 | $58,000 |
20 grants totaling $331K in FY2024 — showing the 15 largest. All grants made by Memorial Sloan-kettering Cancer Center →
| Recipient | Purpose | Amount |
|---|---|---|
| American Cancer Society Inc | Cancer awareness | $75,000 |
| Jamaica Hospital Medical Center | Cancer awareness | $45,000 |
| Susan G Komen Breast Cancer Foundation | Cancer awareness | $25,000 |
| New York Hall of Science | Cancer awareness | $20,000 |
| Long Island Gay and Lesbian Youth Inc | Cancer awareness | $17,500 |
| Housing Help Inc | Cancer awareness | $15,000 |
| Big Brothers Big Sisters of America | Cancer awareness | $15,000 |
| Salvation Army National Corp | Cancer awareness | $13,000 |
| The Hope Center Inc | Cancer awareness | $12,000 |
| Little Sisters of the Assumption Family Health Service | Cancer awareness | $10,000 |
| Green Bronx Machine International Inc | Cancer awareness | $10,000 |
| Figure Skating In Harlem Inc | Cancer awareness | $10,000 |
| Breast Cancer Alliance Inc | Cancer awareness | $10,000 |
| Cancer Support Community Greater Ny & Ct Inc | Cancer awareness | $9,600 |
| Friends of Morningside Park Inc | Cancer awareness | $9,093 |
Explore more
Data for Memorial Sloan-kettering Cancer Center (EIN 91-2154267) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.